Prollenium, a global leader in medical aesthetics, has announced the launch of Revanesse® Renew™+, a new addition to its Revanesse® family of dermal fillers. The product is now available in Canada.
Revanesse® Renew™+ is a skin-boosting injectable designed to deeply hydrate and improve skin quality. Unlike traditional dermal fillers, Renew™+ combines low and high molecular weight hyaluronic acid (HA) in a 100% non-cross-linked, high-purity formula. Its low viscosity allows it to spread easily through the skin, delivering hydration where it’s needed most.
Injected into the upper layers of the skin on the face, neck, or chest, Renew™+ attracts and holds water to smooth skin texture and create a radiant, refreshed appearance.
“This is a first-of-its-kind dermal filler made in Canada,” said Tim Lee, Chief Scientific Officer at Prollenium. “Revanesse® Renew™+ continues our tradition of breakthrough innovations in medical aesthetics, offering a modern solution that helps patients achieve healthy, glowing skin.”
Part of the broader Revanesse® line, Renew™+ supports smoother, plumper skin by hydrating from within and reducing the appearance of fine lines and wrinkles. It also works on the surface of the skin to tone, firm, and lock in moisture, giving patients a more youthful look.
Walter Geiger, acting CEO of Prollenium, emphasized the company’s ongoing commitment to innovation: “This launch reflects our mission to provide health care professionals with top-tier products that help patients feel and look their best.”
The treatment is administered via microinjections using fine needles, spaced about 1 centimeter apart across the treatment area. For best results, two sessions spaced four weeks apart are recommended.
Related topics:
